Unknown

Dataset Information

0

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor.


ABSTRACT: Hepatitis C virus (HCV) infection is a major cause of liver disease. HCV associates with host apolipoproteins and enters hepatocytes through complex processes involving some combination of CD81, claudin-1, occludin, and scavenger receptor BI. Here we show that infectious HCV resembles very low density lipoprotein (VLDL) and that entry involves co-receptor function of the low-density lipoprotein receptor (LDL-R). Blocking experiments demonstrate that beta-VLDL itself or anti-apolipoprotein E (apoE) antibody can block HCV entry. Knockdown of the LDL-R by treatment with 25-hydroxycholesterol or siRNA ablated ligand uptake and reduced HCV infection of cells, whereas infection was rescued upon cell ectopic LDL-R expression. Analyses of gradient-fractionated HCV demonstrate that apoE is associated with HCV virions exhibiting peak infectivity and dependence upon the LDL-R for cell entry. Our results define the LDL-R as a cooperative HCV co-receptor that supports viral entry and infectivity through interaction with apoE ligand present in an infectious HCV/lipoprotein complex comprising the virion. Disruption of HCV/LDL-R interactions by altering lipoprotein metabolism may therefore represent a focus for future therapy.

SUBMITTER: Owen DM 

PROVIDER: S-EPMC2767442 | biostudies-literature | 2009 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor.

Owen David M DM   Huang Hua H   Ye Jin J   Gale Michael M  

Virology 20090913 1


Hepatitis C virus (HCV) infection is a major cause of liver disease. HCV associates with host apolipoproteins and enters hepatocytes through complex processes involving some combination of CD81, claudin-1, occludin, and scavenger receptor BI. Here we show that infectious HCV resembles very low density lipoprotein (VLDL) and that entry involves co-receptor function of the low-density lipoprotein receptor (LDL-R). Blocking experiments demonstrate that beta-VLDL itself or anti-apolipoprotein E (apo  ...[more]

Similar Datasets

| S-EPMC5727422 | biostudies-literature
| S-EPMC2709796 | biostudies-literature
| S-EPMC2818784 | biostudies-literature
| S-EPMC8345860 | biostudies-literature
| S-EPMC2921623 | biostudies-literature
| S-EPMC5301270 | biostudies-literature
| S-EPMC3936477 | biostudies-literature
| S-EPMC6032982 | biostudies-literature
| S-EPMC3059617 | biostudies-literature
| S-EPMC4320993 | biostudies-literature